title: [The Malta project (a program for the eradication of leprosy)].
authors.forename: E
authors.initials: E
authors.lastname: Freerksen
authors.forename: M
authors.initials: M
authors.lastname: Rosenfeld
authors.forename: G
authors.initials: G
authors.lastname: Despasquale
authors.forename: E
authors.initials: E
authors.lastname: Bonnici
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D002648:Child; D003622:Dapsone / Q000008:administration & dosage / Q000627:therapeutic use; D004338:Drug Combinations; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage / Q000627:therapeutic use; D007918:Leprosy / Q000188:drug therapy* / Q000382:microbiology; D008297:Male; D008319:Malta; D051379:Mice; D008875:Middle Aged; D009166:Mycobacterium leprae / Q000502:physiology; D011515:Prothionamide / Q000008:administration & dosage / Q000627:therapeutic use; D012008:Recurrence; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D004338:Drug Combinations; D011515:Prothionamide; D003622:Dapsone; D007538:Isoniazid; D012293:Rifampin
vernacular_title: Le project Malte (un programme d'éradication de la lèpre).